Two stocks in Healthcare
Synektik Spółka Akcyjna vs Zealand Pharma A/S: profit, growth, debt and price compared
Synektik Spółka Akcyjna is stronger on 3 of 6 figures: sales growth, price for its expected profit and price trend. Zealand Pharma A/S is stronger on 2: profit margin and debt.
Save both stocks to your watchlist and revisit their latest fundamentals.
| Synektik Spółka AkcyjnaSNT.WA | Zealand Pharma A/SZEAL.CO | |
|---|---|---|
| Net margin | 44.8% | Stronger: 67.2% |
| Revenue growth, past year | Stronger: +89.50% | −92.00% |
| Debt to equity | 19.4% | Stronger: 2.8% |
| Forward P/E | Stronger: 25.9× | 29.0× |
| Dividend yield | 3.40% | — |
| Analysts | Buy · 5 | Buy · 12 |
| From its 200-day average | Stronger: −3.1% | −31.4% |
Share price over the past year
- Synektik Spółka Akcyjna+20.8%
- Zealand Pharma A/S−58.9%
19 Nov 202520 Nov 2026
Synektik Spółka Akcyjna or Zealand Pharma A/S: which is stronger?
- ZEAL.CO
Which is more profitable?
Zealand Pharma A/S keeps more of each sale as profit: 67.2% against 44.8%.
- SNT.WA
Which is growing its sales faster?
Synektik Spółka Akcyjna is growing its sales faster: +89.50% over the past year, against −92.00%.
- ZEAL.CO
Which has borrowed less?
Zealand Pharma A/S has borrowed less: its debt is 2.8% of what its shareholders own, against 19.4% for Synektik Spółka Akcyjna.
- SNT.WA
Which costs less for the profit it is expected to make?
Synektik Spółka Akcyjna costs less for the profit it is expected to make: 25.9× its forward earnings, against 29.0×.
Which pays more in dividends?
Synektik Spółka Akcyjna pays 3.40% a year in dividends for what a share costs, where Zealand Pharma A/S pays none.
Which do analysts rate higher?
Analysts rate both the same: Buy.
- SNT.WA
Which is in the stronger price trend?
Synektik Spółka Akcyjna's price is in the stronger trend: 3.1% below its 200-day average, against 31.4% below.
What each company does
SNT.WASynektik Spółka Akcyjna
Synektik Spółka Akcyjna provides products, services, and IT solutions for surgery, diagnostic imaging, and nuclear medicine applications in Poland.
ZEAL.COZealand Pharma A/S
Zealand Pharma A/S, a biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States.
Reports results on 25 February 2027
This comparison is just the starting point.
Discover opportunities, understand companies and compare investments in one place. See how StratDeck works
Keep researching
Where next
More comparisons
Free email
Up to speed in minutes, four times a week
Every Monday, know what moved AI stocks and what to watch next. Every Wednesday and Friday, find a stock worth a look and learn its story. Every Sunday, catch up on the market's week in two minutes.
Early access
Become a StratDeck founding user
Use StratDeck, tell us what's missing, and help decide what we build next.
100 founding places. Founding users get their first month free, then half price for life: £2.99 a month or £30 a year.